Inhaled budesonide in the treatment of early COVID-19
The Lancet published on an open-label, parallel-group, phase 2, randomised controlled trial, on inhaled budesonide (Ramakrishnan et al. 2021). Participants
Tag: dry powder inhaler
A forum for researchers, students and applicants in the field of cyclodextrin technology